Pharmaceutical companies are increasingly relying on real-world data (RWD) to accelerate drug development and optimize clinical trial design. Despite this, accessing, analyzing, and interpreting complex RWD is frequently challenging. Datma's Federated Biomarker Explorer provides a innovative solution by presenting a free, effortless platform for RW